Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

CSL Limited

CSLLYPNK
Healthcare
Biotechnology
$50.95
$0.00(0.00%)
U.S. Market opens in 9h 43m

CSL Limited (CSLLY) Stock Overview

Explore CSL Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap100.3B
P/E Ratio34.90
EPS (TTM)$3.08
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$46.12
3 Months$48.40
1 Year Target$44.59

CSLLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CSL Limited (CSLLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $44.59.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 34.90 and a market capitalization of 100.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.67%
5-Day Change
-3.09%
1-Month Change
-16.48%
3-Month Change
-12.07%
6-Month Change
-25.25%
Year-to-Date (YTD) Change
-9.93%
1-Year Change
-37.47%
3-Year Change
-48.45%
5-Year Change
-50.88%
All-Time (Max) Change
354.39%

Contact Information

61 3 9389 1911
45 Poplar Road, Melbourne, VIC, 3052

Company Facts

326,980 Employees
IPO DateDec 29, 2009
CountryAU
Actively Trading

Frequently Asked Questions